Role of Mitochondria in Nonalcoholic Fatty Liver Disease
AbstractNonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the United States and includes a spectrum of disease that includes simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Significant insight has been gained into our understanding of the pathogenesis of NALFD; however the key metabolic aberrations underlying lipid accumulation in hepatocytes and the progression of NAFLD remain to be elucidated. Accumulating and emerging evidence indicate that hepatic mitochondria play a critical role in the development and pathogenesis of steatosis and NAFLD. Here, we review studies that document a link between the pathogenesis of NAFLD and hepatic mitochondrial dysfunction with particular focus on new insights into the role of impaired fatty acid oxidation, the transcription factor peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), and sirtuins in development and progression of NAFLD. View Full-Text
Share & Cite This Article
Nassir, F.; Ibdah, J.A. Role of Mitochondria in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2014, 15, 8713-8742.
Nassir F, Ibdah JA. Role of Mitochondria in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 2014; 15(5):8713-8742.Chicago/Turabian Style
Nassir, Fatiha; Ibdah, Jamal A. 2014. "Role of Mitochondria in Nonalcoholic Fatty Liver Disease." Int. J. Mol. Sci. 15, no. 5: 8713-8742.